Document:

EX-4.1

 Exhibit 4.1 

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE BORROWER THAT SUCH SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS THE SECURITIES ARE REGISTERED
UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE. IN ADDITION, HEDGING TRANSACTIONS INVOLVING SUCH SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. 

SENIOR SECURED PROMISSORY NOTE 
  

			
	$[        ]	 	Dated: August 20, 2015

 FOR VALUE RECEIVED, the undersigned, MARRONE BIO INNOVATIONS, INC. (the “Borrower”), HEREBY
UNCONDITIONALLY PROMISES TO PAY to the order of [        ] (the “Lender”), the principal sum of [        DOLLARS
($        )]1, in installments as set forth in the payment schedule below and with the last such installment to be due and payable on August
    , 20202 (the “Maturity Date”) and in the amount necessary to repay in full the unpaid principal balance hereof. This Senior Secured Promissory Note (this
“Note”) is issued by the Borrower to the Lender pursuant to that certain Purchase Agreement, dated as of August [    ], 2015, by and between the Borrower, the Lender, the other investors party thereto (together with
Lender, the “Lenders”) (the “Purchase Agreement”). Terms used but not defined herein shall have the meaning set forth in Annex I. 
  

	 	1.	Payment Schedule 

  

			
	 PAYMENT SCHEDULE

	 Payment Date
	  	 Amount Due

	 August     , 20183
	  	$[            ]4
	 August     , 20195
	  	$[            ]6
	 Maturity Date
	  	$[            ]7

  

	1 	Allocate among the Lenders. 

	2 	5 years from date of Note 

	3 	3 years from date of Note 

	4 	25% 

	5 	4 years from date of Note 

	6 	25% 

	7 	50% 

  
 1. 

	 	2.	Interest 

 The Borrower further promises to pay interest on the outstanding
principal amount of this Note from the date hereof until maturity at the Maturity Date, in arrears, semi-annually, on June 30 or December 31 of each year, commencing on December 31, 2015, and at maturity at the Maturity Date, at the
rate of 8% per annum. In the event that any amount of principal or interest or any other amount payable hereunder, is not paid in full when due (whether at stated maturity, by acceleration or otherwise), the Borrower agrees to pay interest on
such unpaid principal or other amount, from the date such amount becomes due until the date such amount is paid in full, payable on demand, at a rate of 10% per annum. All computations of interest shall be made on the basis of a year of 365 or
366 days, as the case may be, for the actual number of days (including the first day but excluding the last day) occurring in the period for which such interest is payable. 
  

	 	3.	Payment Terms 

 All payments hereunder shall be made in lawful money of the
United States of America and in same day or immediately available funds, to the Lender, in accordance with the Lender’s payment instructions. 

Whenever any payment hereunder shall be stated to be due, or whenever any interest payment date or any other date specified hereunder would
otherwise occur, on a day other than a Business Day (as defined below), then such payment shall be made, and such interest payment date or other date shall occur, on the next succeeding Business Day, and such extension of time shall in such case be
included in the computation of payment of interest hereunder. As used herein, “Business Day” means a day (i) other than Saturday or Sunday, and (ii) on which commercial banks are open for business in California and Kansas. 

In no event shall the Borrower be obligated to pay the Lender interest, charges or fees at a rate in excess of the highest rate permitted by
applicable law which a court of competent jurisdiction shall, in a final determination, deem applicable hereto. In the event that such a court determines that the Lenders have charged or received interest hereunder in excess of the highest
applicable rate, the rate in effect hereunder shall automatically be reduced to the maximum rate permitted by applicable law and the Lenders shall, at their option (i) promptly refund to the Borrower any interest received by the Lenders in
excess of the maximum lawful rate or (ii) apply such excess to the principal balance of this Note on a pro rata basis. It is the intent hereof that the Borrower not pay or contract to pay, and that the Lenders not receive or contract to
receive, directly or indirectly in any manner whatsoever, interest in excess of that which may be paid by the Borrower under applicable law. 

  
 2. 

	 	4.	Prepayment 

 The Borrower may upon prior notice to the Lender prepay the
outstanding amount hereof in whole or in part at any time, without premium or penalty. Together with any such prepayment the Borrower shall pay accrued interest on the principal amount prepaid. Any partial prepayment shall be applied to the
installments of principal hereof in reverse order of maturity. No such prepaid amount may be reborrowed hereunder. 
  

	 	5.	Affirmative Covenants 

 So long as any amount payable by the Borrower
hereunder shall remain unpaid: 
 (i) Preservation of Existence, Etc. The Borrower will, and will cause of its Subsidiaries to,
maintain and preserve its legal existence, its rights to transact business and all other rights, franchises and privileges necessary or desirable in the normal course of its business and operations and the ownership of its properties. 

(ii) Payment of Taxes. The Borrower will, and will cause of its Subsidiaries to, pay and discharge all taxes, fees, assessments and
governmental charges or levies imposed upon it or upon its properties or assets prior to the date on which penalties attach thereto, and all lawful claims for labor, materials and supplies which, if unpaid, might become a Lien upon any properties or
assets of the Borrower or such Subsidiary, except to the extent such taxes, fees, assessments or governmental charges or levies, or such claims, are being contested in good faith by appropriate proceedings and are adequately reserved against in
accordance with GAAP; provided that the failure to make any such payments shall not constitute a breach of this covenant unless the aggregate amount of such payments could reasonably be expected to exceed $200,000. 

(iii) Maintenance of Insurance. The Borrower will, and will cause of its Subsidiaries to, (i) carry and maintain in full force and
effect insurance in such amounts, with such deductibles and covering such risks as is customarily carried by companies engaged in the same or similar businesses and owning similar properties in the localities where the Borrower or such Subsidiary
operates as determined by the Borrower in its sole discretion (with appropriate endorsements naming the Agent as lender’s loss payee (and mortgagee, as applicable) on all policies for property hazard insurance and as additional insured on all
policies for liability insurance, and if requested by the Agent, copies of such insurance policies and (ii) if requested by the Agent in writing, promptly provide the Agent with such evidence as it reasonably requests to demonstrate compliance
with this Section 5(iii). 
 (iv) Keeping of Records and Books of Account. The Borrower will, and will cause of its Subsidiaries
to, keep proper books, records and accounts (which shall be true and complete in all material respects) as may be required or as may be necessary to permit the preparation of financial statements in accordance with GAAP and in compliance with the
regulations of any governmental authority having jurisdiction over it or any of its properties. 
 (v) Inspection Rights. Upon ten
Business Days’ prior written notice, the Borrower will, and will cause of its Subsidiaries to, at any reasonable time during normal business hours and from time to time, permit the Lender or any of its agents or representatives to visit and
inspect its properties; inspect, audit and make extracts from its books, records and files, including, but not limited to, management letters prepared by independent accountants; and discuss with its principal officers, and its independent
accountants, its business, assets, liabilities, financial condition, results of operations and business prospects. 

  
 3. 

 (vi) Compliance with Laws, Etc. The Borrower will, and will cause of its Subsidiaries to,
comply in all material respects with the requirements of all applicable material laws, rules, regulations and orders of any governmental agency or authority, including all Environmental Laws and ERISA; provided, however, that the Borrower may remain
delinquent in its periodic reporting obligations under the Exchange Act until the completion of the Restatement (as defined in the Purchase Agreement). 

(vii) Maintenance of Properties, Etc. The Borrower will and will cause of its Subsidiaries to, maintain and preserve all of its
material properties necessary or useful in the proper conduct of its business in good working order and condition in accordance with the general practice of other Persons of similar character and size, ordinary wear and tear excepted. 

(viii) Licenses. The Borrower will, and will cause of its Subsidiaries to, obtain and maintain all material licenses, authorizations,
consents, filings, exemptions, registrations and other governmental approvals of any governmental agency or authority necessary for the operation and conduct of its business. 

(ix) Minimum Cash Balance. The Borrower shall maintain a balance consisting of cash and cash equivalents of at least $15,000,000. 

(x) Financial Information. Commencing at such time as the Borrower is no longer required to file periodic reports under the Exchange
Act, the Borrower shall deliver to the Lender: 
 (a) Annual Financial Statements. As soon as practicable and in any
event within ninety (90) days after the end of each fiscal year, an audited consolidated balance sheet of the Borrower and its Subsidiaries as of the close of such fiscal year and audited consolidated statements of income, retained earnings and
cash flows including the notes thereto, all in reasonable detail setting forth in comparative form the corresponding figures as of the end of and for the preceding fiscal year and prepared in accordance with GAAP and, if applicable, containing
disclosure of the effect on the financial position or results of operations of any change in the application of accounting principles and practices during the year. Such annual financial statements shall be audited by an independent certified public
accounting firm of recognized national standing, and accompanied by a report and opinion thereon by such certified public accountants prepared in accordance with generally accepted auditing standards that is not subject to any material qualification
as to the scope of such audit or with respect to accounting principles followed by the Borrower or any of its Subsidiaries not in accordance with GAAP. 

(b) Quarterly Financial Statements. As soon as practicable and in any event within forty-five (45) days after the
end of the first three fiscal quarters of each fiscal year, an unaudited consolidated balance sheet of the Borrower and its 

  
 4. 

 
Subsidiaries as of the close of such fiscal quarter and unaudited consolidated statements of income, retained earnings and cash flows and a report containing management’s discussion and
analysis of such financial statements for the fiscal quarter then ended and that portion of the fiscal year then ended, including the notes thereto, all in reasonable detail setting forth in comparative form the corresponding figures as of the end
of and for the corresponding period in the preceding fiscal year and prepared by the Borrower in accordance with GAAP and, if applicable, containing disclosure of the effect on the financial position or results of operations of any change in the
application of accounting principles and practices during the period, and certified by the chief financial officer of the Borrower to present fairly in all material respects the financial condition of the Borrower and its Subsidiaries on a
consolidated basis as of their respective dates and the results of operations of the Borrower and its Subsidiaries for the respective periods then ended, subject to normal year-end adjustments and the absence of footnotes. 

(xii) Certificates; Other Reports. The Borrower will deliver to the Lender: 

(c) promptly upon receipt thereof, copies of all reports, if any, submitted to the Borrower, any Subsidiary thereof or any of
their respective boards of directors by their respective independent public accountants in connection with their auditing function, including, without limitation, any management report and any management responses thereto; 

(d) promptly after the assertion or occurrence thereof, notice of any action or proceeding against or of any noncompliance by
the Borrower or any Subsidiary thereof with any Environmental Law that could reasonably be expected to have a Material Adverse Effect; 

(e) promptly after the same are available, copies of each annual report, proxy or financial statement or other report or
communication sent to the stockholders of the Borrower, and copies of all annual, regular, periodic and special reports and registration statements which the Borrower may file or be required to file with the SEC under Section 13 or 15(d) of the
Exchange Act, or with any national securities exchange, and in any case not otherwise required to be delivered to the Lender pursuant hereto; 

(f) promptly, and in any event within five (5) Business Days after receipt thereof by the Borrower or any Subsidiary
thereof, copies of each notice or other correspondence received from the SEC (or comparable agency in any applicable non-U.S. jurisdiction) concerning any investigation or possible investigation or other inquiry by such agency regarding financial or
other operational results of the Borrower or any Subsidiary thereof; and 
 (g) such other information regarding the
operations, business affairs and financial condition of the Borrower or any Subsidiary thereof as the Lender may reasonably request. 

  
 5. 

 (xiii) Notice of Litigation and Other Matters 

(a) The Borrower will deliver to the Lender prompt (but in no event later than ten (10) days after any officer of the
Borrower obtains knowledge thereof) written notice of: 
  

	 	(i)	the commencement of all proceedings and investigations by or before any governmental authority and all actions and proceedings in any court or before any arbitrator against or involving any the Borrower or any
Subsidiary thereof or any of their respective properties, assets or businesses that, if adversely determined, could reasonably be expected to have a Material Adverse Effect; 

 

	 	(ii)	any notice of any violation received by the Borrower or any Subsidiary thereof from any governmental authority including, without limitation, any notice of violation of Environmental Laws which in any such case could
reasonably be expected to have a Material Adverse Effect; and 

  

	 	(iii)	(x) any Event of Default or (y) any event or circumstance which constitutes or which with the passage of time or giving of notice or both would constitute an Event of Default. 

(xiv) Additional Subsidiaries. The Borrower will notify the Agent of the creation or acquisition of any new domestic Subsidiary and
promptly thereafter (and in any event within thirty (30) days after such creation or acquisition), cause such Person to (i) become a Subsidiary Guarantor by delivering to the Agent a duly executed Subsidiary Guaranty Agreement (or
supplement thereto) or such other document as the Agent shall deem appropriate for such purpose, (ii) grant a security interest in all Collateral (subject to the exceptions specified in the Security Agreement) owned by such Subsidiary by
delivering to the Agent a duly executed supplement to each Security Document or such other document as the Agent shall deem appropriate for such purpose and comply with the terms of each Security Document, (iii) deliver to the Agent such
original Capital Stock or other certificates and stock or other transfer powers evidencing the Capital Stock of such Person, (iv) deliver to the Agent such updated Schedules to the Loan Documents as requested by the Agent with respect to such
Person, and (v) deliver to the Agent such other documents as may be reasonably requested by the Agent, all in form, content and scope reasonably satisfactory to the Agent. 

 

	 	6.	Negative Covenants 

 So long as any amount payable by the Borrower
hereunder shall remain unpaid neither the Borrower nor any of its Subsidiaries will: 
 (i) Indebtedness. Create, incur, assume or
otherwise become liable for or suffer to exist any Indebtedness, other than Permitted Indebtedness. 

  
 6. 

 (ii) Fundamental Changes. Merge, consolidate or enter into any similar combination with
any other Person or liquidate, wind-up or dissolve itself (or suffer any liquidation or dissolution) except: 
 (b)
(i) any wholly-owned Subsidiary of the Borrower may be merged, amalgamated or consolidated with or into the Borrower (provided that the Borrower shall be the continuing or surviving entity), (ii) any wholly-owned Subsidiary of the
Borrower may be merged, amalgamated or consolidated with or into any Subsidiary Guarantor (provided that the Subsidiary Guarantor shall be the continuing or surviving entity or simultaneously with such transaction, the continuing or surviving
entity shall become a Subsidiary Guarantor), and (iii) any wholly-owned Subsidiary of the Borrower may be merged, amalgamated or consolidated with or into any other wholly-owned Subsidiary that is not a Subsidiary Guarantor; provided that the
surviving entity is a Subsidiary Guarantor; 
 (c) any Subsidiary may dispose of all or substantially all of its assets (upon
voluntary liquidation, dissolution, winding up or otherwise) to the Borrower or any other Subsidiary; provided that, with respect to any such disposition by any Subsidiary that is not a Subsidiary Guarantor, the consideration for such
disposition shall not exceed the fair value of such assets; 
 (d) dispositions permitted by Section 6(v); and

 (e) any Person may merge into the Borrower or any of its wholly-owned Subsidiaries in connection with a Permitted
Acquisition; provided that (i) in the case of a merger involving the Borrower or a Subsidiary Guarantor, the continuing or surviving Person shall be the Borrower or such Subsidiary Guarantor and (ii) the continuing or surviving
Person shall be the Borrower or a wholly-owned Subsidiary of the Borrower. 
 (iii) Investments. Purchase, own, invest in or
otherwise acquire (in one transaction or a series of transactions), directly or indirectly, any Capital Stock, interests in any partnership or joint venture (including, without limitation, the creation or capitalization of any Subsidiary), evidence
of Indebtedness or other obligation or security, substantially all or a portion of the business or assets of any other Person or any other investment or interest whatsoever in any other Person, or make or permit to exist, directly or indirectly, any
loans, advances or extensions of credit to, or any investment in cash or by delivery of Property in, any Person (all the foregoing, “Investments”) except: 

(a) Investments existing on the Closing Date in Subsidiaries existing on the Closing Date; 

(b) Investments in cash and cash equivalents; 

(c) Investments by the Borrower or any of its Subsidiaries in the form of capital expenditures permitted pursuant to this
Agreement; 
 (d) deposits made in the ordinary course of business to secure the performance of leases or other obligations;

 (e) purchases of assets in the ordinary course of business; 

  
 7. 

 (f) Investments by the Borrower or any Subsidiary thereof in the form of
Permitted Acquisitions to the extent that any Person or property acquired in such acquisition becomes a part of the Borrower or a Subsidiary Guarantor or becomes a Subsidiary Guarantor in the manner contemplated by Section 5(xiii); 

(g) Investments in the form of loans and advances to officers, directors and employees in the ordinary course of business in an
aggregate amount not to exceed at any time outstanding $150,000 (determined without regard to any write-downs or write-offs of such loans or advances); 

(h) Investments not otherwise permitted pursuant to this Section in an aggregate amount not to exceed $250,000 at any time
outstanding; provided that, immediately before and immediately after giving pro forma effect to any such Investments, no Default or Event of Default shall have occurred and be continuing. 

(iv) Liens. Create, incur, assume or suffer to exist, any Lien on or with respect to any of its property, whether now owned or
hereafter acquired, except the following Liens (“Permitted Liens”): 
 (i) Liens created pursuant to the
Loan Documents; 
 (j) Liens in existence on the Closing Date and described on Schedule 6(iv), including Liens
incurred in connection with any refinancing, refunding, renewal or extension of Indebtedness; provided that the scope of any such Lien shall not be increased, or otherwise expanded, to cover any additional property or type of asset, as
applicable, beyond that in existence on the Closing Date, except for products and proceeds of the foregoing; 
 (k) Liens for
taxes, assessments and other governmental charges or levies (excluding any Lien imposed pursuant to any of the provisions of ERISA or Environmental Laws) (i) not yet due or as to which the period of grace (not to exceed thirty (30) days),
if any, related thereto has not expired or (ii) which are being contested in good faith and by appropriate proceedings if adequate reserves are maintained to the extent required by GAAP; 

(l) the claims of materialmen, mechanics, carriers, warehousemen, processors or landlords for labor, materials, supplies or
rentals incurred in the ordinary course of business, which (i) if overdue, no action to Borrower’s knowledge has been taken to enforce such Liens and such Liens are being contested in good faith and by appropriate proceedings if adequate
reserves are maintained to the extent required by GAAP and (ii) do not, individually or in the aggregate, materially impair the use thereof in the operation of the business of the Borrower or any of its Subsidiaries; 

(m) Liens consisting of deposits or pledges made in the ordinary course of business in connection with, or to secure payment
of, obligations under workers’ compensation, unemployment insurance and other types of social security or 

  
 8. 

 
similar legislation, or to secure the performance of bids, trade contracts and leases (other than Indebtedness), statutory obligations, surety bonds (other than bonds related to judgments or
litigation), performance bonds and other obligations of a like nature incurred in the ordinary course of business, in each case, so long as no foreclosure sale or similar proceeding has been commenced with respect to any portion of the Collateral on
account thereof; 
 (n) Purported Liens evidenced by the filing of precautionary UCC financing statements relating solely to
personal property leased pursuant to operating leases entered into in the ordinary course of business of the Borrower and its Subsidiaries; 

(o) Liens securing judgments for the payment of money not constituting an Event of Default or securing appeal or other surety
bonds relating to such judgments; 
 (p) (i) Liens of a collecting bank arising in the ordinary course of business under
Section 4-210 of the Uniform Commercial Code in effect in the relevant jurisdiction and (ii) Liens of any depositary bank in connection with statutory, common law and contractual rights of set-off and recoupment with respect to any deposit
account of any Borrower or any Subsidiary thereof; 
 (q) (i) contractual or statutory Liens of landlords to the extent
relating to the property and assets relating to any lease agreements with such landlord, and (ii) contractual Liens of suppliers (including sellers of goods) or customers granted in the ordinary course of business to the extent limited to the
property or assets relating to such contract; 
 (r) any interest or title of a licensor, sublicensor, lessor or sublessor
with respect to any assets under any license or lease agreement entered into in the ordinary course of business which do not (i) interfere in any material respect with the business of the Borrower or its Subsidiaries or materially detract from
the value of the relevant assets of the Borrower or its Subsidiaries or (ii) secure any Indebtedness; 
 (s) Liens
securing Purchase Money Indebtedness; 
 (t) Liens securing Subordinated Debt, pursuant to a subordination agreement in form
and substance satisfactory to the Agent; 
 (u) Liens existing on such property at the time of its acquisition in connection
with a Permitted Acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon; 

(v) Liens not otherwise permitted hereunder on assets other than the Collateral securing Indebtedness or other obligations in
the aggregate principal amount not to exceed $250,000 at any time outstanding. 

  
 9. 

 (v) Asset Dispositions. Make any disposition of any or all of the assets (including,
without limitation, any Capital Stock owned thereby) whether by sale, lease, transfer or otherwise, except the sale of inventory in the ordinary course of business and the sale of obsolete, worn-out or surplus assets no longer used or usable in the
business of the Borrower or any of its Subsidiaries. 
 (vi) Restricted Payments. Declare or pay any dividend on, or make any payment
or other distribution on account of, or purchase, redeem, retire or otherwise acquire (directly or indirectly), or set apart assets for a sinking or other analogous fund for the purchase, redemption, retirement or other acquisition of, any class of
Capital Stock of any the Borrower or any Subsidiary thereof, or make any distribution of cash, property or assets to the holders of shares of any Capital Stock of the Borrower or any Subsidiary thereof (all of the foregoing, the “Restricted
Payments”) provided that: 
 (a) the Borrower or any Subsidiary thereof may pay dividends in shares of its own
Capital Stock; and 
 (b) any Subsidiary of the Borrower may pay cash dividends to the Borrower. 

(vii) Line of Business. Engage in any business other than the business conducted by the Borrower and its Subsidiaries as of the Closing
Date and business activities reasonably related or ancillary thereto or that are reasonable extensions thereof. 
 (viii) Use of
Proceeds. Use any part of the proceeds of any of the Loans for purchasing or carrying margin stock or for any purpose which violates, or which would be inconsistent with, the provisions of Regulation T, U or X of such Board of Governors. 

(ix) Rule 17a-6. Take any action, or fail to take any action, that could cause any Lender to fail to satisfy the safe harbor provisions
of Rule 17a-6 under the Investment Company Act of 1940, as amended. 
  

	 	7.	Events of Default 

 The occurrence of any of the following shall
constitute an “Event of Default” under this Note: 
 (i) the failure to make any payment of principal, interest (to the extent not
added to the principal as provided herein) or any other amount payable hereunder when due under this Note, and the continuation of such failure for two (2) Business Days; 

(ii) Any representation or warranty by the Borrower or any Subsidiary under any Loan Document shall prove to have been incorrect in any
material respect when made or deemed made; 
 (iii) the breach of any other condition or obligation under this Note or any other Loan
Document and the continuation of such breach for thirty (30) days after notice thereof from the Agent or knowledge thereof by Borrower; 

  
 10. 

 (iv) the filing of a petition by or against the Borrower or any Subsidiary under any provision of
the Bankruptcy Reform Act, Title 11 of the United States Code, as amended or recodified from time to time (the “Bankruptcy Code”), or under any similar law relating to bankruptcy, insolvency or other relief for debtors (provided, in the
case of an involuntary petition, that such the filing is not dismissed, removed or stayed within thirty (30) days of the institution thereof); or appointment of a receiver, trustee, custodian or liquidator of or for all or any part of the
assets or property of the Borrower; or the insolvency of the Borrower; or the making of a general assignment for the benefit of creditors by the Borrower; 

(v) the Borrower or any Subsidiary shall (i) liquidate, wind-up or dissolve (or suffer any liquidation, wind-up or dissolution),
(ii) suspend its operations other than in the ordinary course of business, or (iii) take any action to authorize any of the actions or events set forth above in paragraph 5; 

(vi) (i) the Borrower, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Borrower with or
into another Person (but excluding a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Borrower), (ii) the Borrower, directly or indirectly, effects any sale, assignment, transfer or other
disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Borrower or another Person) is completed pursuant to
which holders of common stock of the Borrower are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding common stock of the Borrower or
(iv) the Borrower, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the common stock of the Borrower or any compulsory share exchange pursuant to which the common
stock of the Borrower is effectively converted into or exchanged for other securities, cash or property; 
 (vii) any event of default under
the Security Agreement (as defined below) shall have occurred and be continuing; or the Security Agreement or any of the other documents relating to the Collateral after delivery thereof shall for any reason be revoked or invalidated, or otherwise
cease to be in full force and effect, or the Borrower or any other Person shall contest in any manner the validity or enforceability thereof, or the Borrower or any other Person shall deny that it has any further liability or obligation thereunder;
or the Security Agreement or any of the other documents relating to the Collateral for any reason, except to the extent permitted by the terms thereof, shall cease to create a valid and perfected lien in any of the Collateral purported to be covered
thereby; 
 (viii) there is under any agreement to which Borrower or any Subsidiary is a party with a third party or parties any default
resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of Five Million Dollars ($5,000,000); 

(ix) one or more final judgments, orders, or decrees for the payment of money in an amount, individually or in the aggregate, of at least Five
Million Dollars ($5,000,000) (not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower or any Subsidiary and the same are not, within thirty (30) days
after the entry thereof, discharged or execution thereof stayed or bonded pending appeal, or such judgments are not discharged prior to the expiration of any such stay; 

  
 11. 

 (x) the acquisition by any Person, or two or more Persons acting as a “group” (other
than the Lender and any Person with whom the Lender is acting in a group or to whom the Lender has directly or indirectly transferred any of the shares of the Borrower of which the Lender has now or becomes entitled to acquire “beneficial
ownership”, and the affiliates of the Lender and such other Persons) (as such terms are defined in Rules 13d-5 13d-3 of the Securities and Exchange Commission under the Securities Exchange Act of 1934) beneficial ownership of 40% or more of the
outstanding shares of voting stock of the Borrower; or 
 (xi) the 90th day following the date of a Key Person Event unless, on or prior to
such 90th day, the Board appoints an individual reasonably acceptable to Lender as the chief executive officer of the Borrower. 
  

	 	8.	Remedies and Enforcement 

 Upon the occurrence and continuance of any Event
of Default, the Agent, at its option, may (i) by notice to the Borrower, declare the unpaid principal amount of this Note, all interest accrued and unpaid hereon and all other amounts payable hereunder to be immediately due and payable,
whereupon the unpaid principal amount of this Note, all such interest and all such other amounts shall become immediately due and payable, without presentment, demand, protest or further notice of any kind, provided that upon the occurrence
of an actual or deemed entry of an order for relief with respect to the Borrower under the Bankruptcy Code, the result which would otherwise occur only upon giving of notice by the Agent to the Borrower as specified above shall occur automatically,
without the giving of any such notice; and (ii) whether or not the actions referred to in clause (i) have been taken, exercise any or all of the Agent’s rights and remedies under the Security Agreement and proceed to enforce all other
rights and remedies available to the Agent under applicable law. 
 The Borrower agrees to pay on demand all the losses, costs, and expenses
(including, without limitation, attorneys’ fees and disbursements) which the Agent incurs in connection with enforcement or attempted enforcement of this Note, or the protection or preservation of the Lender’s rights under this Note,
whether by judicial proceedings or otherwise. Such costs and expenses include, without limitation, those incurred in connection with any workout or refinancing, or any bankruptcy, insolvency, liquidation or similar proceedings. 

The Borrower hereby waives diligence, demand, presentment, protest or further notice of any kind. 

 

	 	9.	Miscellaneous 

 Time is of the essence for the performance of each
and every obligation under this Note. 
 The Borrower agrees to make all payments under this Note without setoff or deduction and regardless
of any counterclaim or defense. 

  
 12. 

 No single or partial exercise of any power under this Note shall preclude any other or further
exercise of such power or exercise of any other power. No delay or omission on the part of the Agent in exercising any right under this Note shall operate as a waiver of such right or any other right hereunder. 

This Note shall be binding on the Borrower and its successors and assigns, and shall be binding upon and inure to the benefit of the Lender,
any future holder of this Note and their respective successors and assigns. 
 Except as otherwise provided herein or in any other Loan
Document, (i) no amendment to any provision of this Note or any of the other Loan Documents shall in any event be effective unless the same shall be in writing and signed by the Borrower and the Lender; and (ii) no waiver of any provision
of this Note or any other Loan Document, or consent to any departure by the Borrower or other party therefrom, shall in any event be effective unless the same shall be in writing and signed by the Borrower and the Lender. 

The Borrower will maintain a register in which it will record the initial ownership of this Note and any changes in ownership of this Note
which occur as permitted by and in compliance with the terms hereof. 
 The Borrower shall not have the right to assign its rights and
obligations hereunder or any interest herein or therein without the prior written consent of the Lender. The Lender may sell, assign, transfer or grant participations in all or any portion of the Lender’s rights and obligations hereunder. In
the event of any such assignment, upon notice thereof to the Borrower, the assignee shall be deemed the “Lender” for all purposes of this Note and any other documents and instruments relating hereto with respect to the rights and
obligations assigned to it. The Borrower agrees that in connection with any such grant or assignment, the Lender may deliver to the prospective participant or assignee financial statements and other relevant information relating to the Borrower and
its subsidiaries. 
 All notices and other communications provided for hereunder shall, unless otherwise stated herein, be in writing
(including by facsimile) and mailed (by certified or registered mail), sent or delivered (i) if to the Lender,             , attn.
            , fax
(        )         -        ; and (ii) if to the Borrower, at or to its address
or facsimile number set forth below its name on the signature page hereof, or at or to such other address or facsimile number as such party shall have designated in a written notice to the other party. All such notices and communications shall be
effective (i) if delivered by hand, sent by certified or registered mail or sent by an overnight courier service, when received; and (ii) if sent by facsimile transmission, when sent. 

This Note is secured by certain collateral (the “Collateral”) more specifically described in the Security Agreement of even date
herewith between the Borrower and Ivy Investment Management Corp., a Delaware corporation, as agent for the Lenders (the “Agent”) (the “Security Agreement”). 

THIS NOTE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH CALIFORNIA LAW WITHOUT GIVING EFFECT TO ANY

  
 13. 

 
CHOICE OF LAW RULE THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE INTERNAL LAWS OF THE STATE OF CALIFORNIA TO THE RIGHTS AND DUTIES OF THE PARTIES. 

The Borrower hereby (i) submits to the non-exclusive jurisdiction of the courts of the State of California and the Federal courts of the
United States sitting in San Francisco, California for the purpose of any action or proceeding arising out of or relating to this Note and any other documents and instruments relating hereto, (ii) agrees that all claims in respect of any such
action or proceeding may be heard and determined in such courts, (iii) irrevocably waives (to the extent permitted by applicable law) any objection which it now or hereafter may have to the laying of venue of any such action or proceeding
brought in any of the foregoing courts, and any objection on the ground that any such action or proceeding in any such court has been brought in an inconvenient forum and (iv) agrees that a final judgment in any such action or proceeding shall
be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner permitted by law. 
 THE BORROWER
AND, BY ITS ACCEPTANCE HEREOF, THE LENDER, HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO THIS NOTE. IN THE EVENT ANY LEGAL PROCEEDING IS FILED IN A COURT OF THE
STATE OF CALIFORNIA (THE “COURT”) BY OR AGAINST ANY PARTY IN CONNECTION WITH ANY CONTROVERSY, DISPUTE OR CLAIM DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS NOTE OR THE TRANSACTIONS CONTEMPLATED HEREBY (EACH, A
“CLAIM”) AND THE WAIVER SET FORTH IN THE PRECEEDING PARAGRAPH IS NOT ENFORCEABLE IN SUCH ACTION OR PROCEEDING, THE BORROWOR HEREBY AGREES, AND THE LENDER BY ITS ACCEPTANCE HEREOF HEREBY AGREES, AS FOLLOWS: 

(1) WITH THE EXCEPTION OF THE MATTERS SPECIFIED IN SUBPARAGRAPH 2 BELOW, ANY CLAIM WILL BE RESOLVED BY A GENERAL REFERENCE PROCEEDING IN
ACCORDANCE WITH THE PROVISIONS OF CALIFORNIA CODE OF CIVIL PROCEDURE SECTIONS 638 THROUGH 645.1. 
 (2) THE FOLLOWING MATTERS SHALL NOT BE
SUBJECT TO A REFERENCE PROCEEDING: (A) NON-JUDICIAL FORECLOSURE OF ANY SECURITY INTERESTS IN REAL OR PERSONAL PROPERTY, (B) EXERCISE OF SELF-HELP REMEDIES (INCLUDING SET-OFF), (C) APPOINTMENT OF A RECEIVER AND (D) TEMPORARY,
PROVISIONAL OR ANCILLARY REMEDIES (INCLUDING WRITS OF ATTACHMENT, WRITS OF POSSESSION, TEMPORARY RESTRAINING ORDERS OR PRELIMINARY INJUNCTIONS). THIS NOTE DOES NOT LIMIT THE RIGHT OF ANY PARTY TO EXERCISE OR OPPOSE ANY OF THE RIGHTS AND REMEDIES
DESCRIBED IN CLAUSES (A) - (D) AND ANY SUCH EXERCISE OR OPPOSITION DOES NOT WAIVE THE RIGHT OF ANY PARTY TO A REFERENCE PROCEEDING PURSUANT TO THIS NOTE. 

(3) UPON THE WRITTEN REQUEST OF ANY PARTY, THE PARTIES SHALL SELECT A SINGLE REFEREE, WHO SHALL BE A RETIRED JUDGE OR

  
 14. 

 
JUSTICE. IF THE PARTIES DO NOT AGREE UPON A REFEREE WITHIN TEN DAYS OF SUCH WRITTEN REQUEST, THEN, ANY PARTY MAY REQUEST THE COURT TO APPOINT A REFEREE PURSUANT TO CALIFORNIA CODE OF CIVIL
PROCEDURE SECTION 640(B). A REQUEST FOR APPOINTMENT OF A REFEREE MAY BE HEARD ON AN EX PARTE OR EXPEDITED BASIS, AND THE PARTIES AGREE THAT IRREPARABLE HARM WOULD RESULT IF EX PARTE RELIEF IS NOT GRANTED. 

(4) ALL PROCEEDINGS AND HEARINGS CONDUCTED BEFORE THE REFEREE, EXCEPT FOR TRIAL, SHALL BE CONDUCTED WITHOUT A COURT REPORTER, EXCEPT WHEN ANY
PARTY SO REQUESTS, A COURT REPORTER WILL BE USED AND THE REFEREE WILL BE PROVIDED A COURTESY COPY OF THE TRANSCRIPT. THE PARTY MAKING SUCH REQUEST SHALL HAVE THE OBLIGATION TO ARRANGE FOR AND PAY COSTS OF THE COURT REPORTER, PROVIDED THAT SUCH
COSTS, ALONG WITH THE REFEREE’S FEES, SHALL ULTIMATELY BE BORNE BY THE PARTY WHO DOES NOT PREVAIL, AS DETERMINED BY THE REFEREE. 
 (5)
THE REFEREE SHALL APPLY THE RULES OF DISCOVERY AND EVIDENCE APPLICABLE TO PROCEEDINGS AT LAW IN THE STATE OF CALIFORNIA TO THE REFERENCE PROCEEDING AND SHALL DETERMINE ALL ISSUES IN ACCORDANCE WITH APPLICABLE LAW. THE REFEREE SHALL BE EMPOWERED TO
ENTER EQUITABLE AS WELL AS LEGAL RELIEF AND RULE ON ANY MOTION WHICH WOULD BE AUTHORIZED IN A TRIAL, INCLUDING MOTIONS FOR DEFAULT JUDGMENT OR SUMMARY JUDGMENT. THE REFEREE SHALL REPORT HIS DECISION, WHICH REPORT SHALL ALSO INCLUDE FINDINGS OF FACT
AND CONCLUSIONS OF LAW. 
 [Remainder of page left intentionally blank] 

  
 15. 

 IN WITNESS WHEREOF, the Borrower has duly executed this Note, as of the date first above written.

  

			
	MARRONE BIO INNOVATIONS, INC.
		
	By    	 	  

		 	Title:
	
	Address:
	
	  

	
	  

	
	  

 [Signature Page to Senior Secured Promissory Note] 

 ANNEX I 

DEFINITIONS 
 As used in the
Note, the following terms shall have the following meanings: 
 “Acquired Indebtedness” means Indebtedness of a Person whose assets or stock
is acquired by the Borrower in a Permitted Acquisition; provided, however, that such Indebtedness (i) was in existence prior to the date of such Permitted Acquisition, and (ii) was not incurred in connection with, or in
contemplation of, such Permitted Acquisition. 
 “Capital Stock” means (a) in the case of a corporation, capital stock, (b) in
the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of capital stock, (c) in the case of a partnership, partnership interests (whether general or
limited), (d) in the case of a limited liability company, membership interests, (e) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the
issuing Person and (f) any and all warrants, rights or options to purchase any of the foregoing. 
 “Contingent Obligation” is, for
any Person, any direct or indirect liability, contingent or not, of that Person for (a) any indebtedness, lease, dividend, letter of credit or other obligation of another such as an obligation directly or indirectly guaranteed, endorsed,
co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable; (b) any obligations for undrawn letters of credit for the account of that Person; and (c) all obligations from any
interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices; but
“Contingent Obligation” does not include endorsements in the ordinary course of business. The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent Obligation is made or, if
not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement. 

“Environmental Laws” means all federal, state or local laws, statutes, common law duties, rules, regulations, ordinances and codes, together
with all administrative orders, directives, requests, licenses, authorizations and permits of, and agreements with (including consent decrees), any governmental agencies or authorities, in each case relating to or imposing liability or standards of
conduct concerning public health, safety and environmental protection matters. 
 “ERISA” means the Employee Retirement Income Security Act
of 1974, including (unless the context otherwise requires) any rules or regulations promulgated thereunder. 
 “Indebtedness” is
(a) indebtedness for borrowed money or the deferred price of property or services, such as reimbursement and other obligations for surety bonds and letters of credit, (b) obligations evidenced by notes, bonds, debentures or similar
instruments, (c) capital lease obligations and (d) Contingent Obligations. 

 “Key Person” means Pamela Marrone. 

“Key Person Event” means the date on which the Key Person ceases to be employed as the chief executive officer of the Borrower, unless such
cessation either (x) occurs after December 31, 2017 or (y) is a result of any of the following: 
 a. The Key Person dies or
suffers a permanent disability, or other physical incapacity, that prevents her from discharging her duties as chief executive officer of the Borrower; 

b. The Key Person (i) suffers a legal incapacity that prevents her from discharging her duties as chief executive officer of the Borrower
or (ii) is otherwise prohibited from discharging her duties as chief executive officer of the Borrower due to any law, rule, or regulation or any final judgement, order or decree of any court or governmental agency; or 

c. The Board, acting by the affirmative vote of at least 80% of the members of the Board (excluding the vote of the Key Person), removes the
Key Person as chief executive officer of the Borrower. 
 “Lien” means any mortgage, deed of trust, pledge, security interest, assignment,
deposit arrangement, charge or encumbrance, lien, or other type of preferential arrangement. 
 “Loan Documents” means the Purchase
Agreement, the Note, the Security Agreement, the Subsidiary Guaranty, any Subordination Agreement, and all other certificates, documents, agreements and instruments required to be delivered to the Lender or the Agent under or in connection with the
Note. 
 “Obligations” means the indebtedness, liabilities and other obligations of the Borrower to the Lender under or in connection with
the Note and the other Loan Documents and, including, without limitation, all unpaid principal of the Note, all interest accrued thereon, all fees and all other amounts payable by the Borrower to the Lender thereunder or in connection therewith,
whether now existing or hereafter arising, and whether due or to become due, absolute or contingent, liquidated or unliquidated, determined or undetermined, and including interest that accrues after the commencement by or against the Borrower of any
bankruptcy or insolvency proceeding naming such Person as the debtor in such proceeding. 
 “Person” is any individual, sole
proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.

 “Permitted Acquisition” means any acquisition made by the Borrower with the prior consent of the Lender. 

 “Permitted Indebtedness” means: 

 

	(i)	Indebtedness of the Borrower to the Lender; 

  

	(ii)	Indebtedness of the Borrower existing on the date hereof and disclosed to the Lender on Schedule 6(i) and extensions, renewals and refinancings of such Indebtedness, provided that the principal amount of
such Indebtedness is not increased except by an amount equal to a reasonable premium or other reasonable amount paid, and fees and expenses reasonably incurred, in connection with such extension, renewal or refinancing and by an amount equal to any
existing unused commitments thereunder; 

  

	(iii)	trade, utility or non-extraordinary accounts payable arising in the ordinary course of business; 

  

	(iv)	Purchase Money Indebtedness; 

  

	(v)	cash management agreements in the ordinary course of business; 

  

	(vi)	Indebtedness arising from judgments or decrees in an aggregate principal amount outstanding at any time not to exceed $5,000,000; 

  

	(vii)	sales rebates issued by the Borrower to customers in the ordinary course of business; 

  

	(viii)	grants provided by the United States government in exchange for the Borrower’s obligation to purchase equipment specified by such grants or to fund research and development efforts specified in such grants;

  

	(ix)	Indebtedness that is incurred on the date of the consummation of a Permitted Acquisition solely for the purpose of consummating such Permitted Acquisition so long as no Event of Default has occurred and is continuing or
would result therefrom; 

  

	(x)	Acquired Indebtedness; 

  

	(xi)	Indebtedness consisting of guarantees resulting from endorsement of negotiable instruments for collection by the Borrower in the ordinary course of business; 

 

	(xii)	interest rate swaps, currency swaps and similar financial products entered into or obtained in the ordinary course of business; 

  

	(xiii)	Subordinated Debt; 

  

	(xiv)	Indebtedness of the Borrower to any of its wholly owned Subsidiaries; 

  

	(xv)	Indebtedness of the Borrower pursuant to a working capital facility secured by a first priority security interest in the Borrower’s Accounts (as such term is defined in the UCC) and Inventory (as such term is
defined in the UCC); and 

  

	(xviii)	additional Indebtedness of the Borrower with the prior consent of the Lender. 

 “Purchase Money Indebtedness” means Indebtedness incurred to finance the acquisition of fixed
assets, capital assets (whether pursuant to a loan, a capitalized lease or otherwise) or other assets (including manufacturing plants), including the development, furnishing and operation hereof. 

“Subordinated Debt” means any Indebtedness of the Borrower subordinated to the Obligations and either subject to a Subordination Agreement or
whereby the creditor or creditors for such Indebtedness unilaterally agree to subordinate fully the Borrower’s obligations to such creditor or creditors to all Indebtedness of the Borrower owing to the Lender in terms of rights of payment,
liens and exercise of remedies. 
 “Subsidiary” means as to any Person, any corporation, partnership, limited liability company or other
entity of which more than fifty percent (50%) of the outstanding Capital Stock having ordinary voting power to elect a majority of the board of directors (or equivalent governing body) or other managers of such corporation, partnership, limited
liability company or other entity is at the time owned by (directly or indirectly) or the management is otherwise controlled by (directly or indirectly) such Person (irrespective of whether, at the time, Capital Stock of any other class or classes
of such corporation, partnership, limited liability company or other entity shall have or might have voting power by reason of the happening of any contingency). Unless otherwise qualified, references to “Subsidiary” or
“Subsidiaries” herein shall refer to those of the Borrower. 
 “Subsidiary Guarantor” means each new Subsidiary of Borrower
formed after the date hereof that executes the Subsidiary Guaranty or a supplement to such Subsidiary Guaranty. 
 “Subsidiary Guaranty”
means a guaranty executed and delivered in favor of the Lender by a new Subsidiary of Borrower formed after the date hereof. 
 “Subordination
Agreement” means any subordination agreement with respect to Subordinated Debt among the Borrower, the applicable creditor(s) and the Lender or the Agent (on behalf of the Lender), in form and substance reasonably satisfactory to the Lender
or the Agent (on behalf of the Lender). 
 “UCC” means the Uniform Commercial Code as the same may, from time to time, be in effect in the
State of California. 

 SCHEDULES TO THE NOTE 

Schedule 6(i) 

Existing Indebtedness 

“Five Star Debt” means indebtedness under the Business Loan Agreement, dated as of June 13, 2014, by and among the Borrower,
Marrone Michigan Manufacturing, LLC (“MMM”) and Five Star Bank as lender, as amended by the Consent, dated as of August 19, 2015. 

“Snyder Debt” means indebtedness under the Snyder Loan Agreement (Deal A). 

“Snyder Loan Agreement (Deal A)” means the Loan Agreement, dated as of October 2, 2012, by and among the Borrower, the lenders
from time to time party thereto, and Gordon Snyder, as administrative agent and collateral agent for such lenders, as amended by that Amendment and Consent, dated as of April 10, 2013, and that Omnibus Amendment to Loan Agreement, dated as of
August 19, 2015, between the Borrower and Gordon Snyder as administrative agent and collateral agent for the lenders. 
 The Borrower (together with
MMM) had an aggregate of approximately $1,502,000 outstanding under various capital leases and equipment leases, secured by liens set forth on Schedule 6(iv). 

 SCHEDULES TO THE NOTE 

Schedule 6(iv) 

Existing Liens 
  

													
	 	 	 Secured Party
	  	Initial Filing
Number	 	  	Initial
Filing Date	 	  	Collateral
Description
	1	 	 Manufacturers’ Lease Plans, Inc.
	  	 	2009 2917117	  	  	 	9/11/2009	  	  	Equipment
	2	 	 Thermo Fisher Financial Services Inc.
	  	 	2011 0842388	  	  	 	3/8/2011	  	  	Equipment
	3	 	 Manufacturers’ Lease Plans, Inc.
	  	 	2011 1307423	  	  	 	4/7/2011	  	  	Equipment
	4	 	 Manufacturers’ Lease Plans, Inc.
	  	 	2011 1486599	  	  	 	4/20/2011	  	  	Equipment
	5	 	 Thermo Fisher Financial Services Inc.
	  	 	2012 1830845	  	  	 	5/11/2012	  	  	Equipment
	6	 	 Manufacturers’ Lease Plans, Inc.
	  	 	2012 2469296	  	  	 	6/26/2012	  	  	Equipment
	7	 	 Farnam Street Financial, Inc.
	  	 	2012 2776104	  	  	 	7/19/2012	  	  	Equipment
	8	 	 Gordon Snyder, as agent
	  	 	2012 4188282	  	  	 	10/31/12	  	  	All assets
	9	 	 Thermo Fisher Financial Services Inc.
	  	 	2013 0600800	  	  	 	2/14/2013	  	  	Equipment
	10	 	 Thermo Fisher Financial Services Inc.
	  	 	2013 1743864	  	  	 	5/7/2013	  	  	Equipment
	11	 	 Farnam Street Financial, Inc.
	  	 	2013 2466804	  	  	 	6/27/2013	  	  	Equipment
	12	 	 Manufacturers’ Lease Plans, Inc.
	  	 	2014 2251668	  	  	 	6/10/2014	  	  	Equipment
	13	 	 Five Star Bank
	  	 	2014 3526878	  	  	 	9/3/2014	  	  	All assets
of MMM
and MBI*

  

	*	Initial Financing Statement 2014-3526878 by Five Star Bank shall be amended on or around the date of this Note by Five Star Bank to amend the collateral description to all assets of MMM and the Borrower’s deposit
accounts with Five Star Bank (#3207933 and #3208014) only.EX-4.2

 Exhibit 4.2 

EXECUTION COPY 
 FORM OF
WARRANT 
 Warrant Certificate No.                  

THE SECURITIES REPRESENTED HEREBY (AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF) HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR
OTHERWISE TRANSFERRED UNLESS THE SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE. IN ADDITION, HEDGING TRANSACTIONS INVOLVING SUCH SECURITIES MAY NOT BE
CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. 
  

			
	Effective Date: August 20, 2015	  	Void After: August 20, 2023

 MARRONE BIO INNOVATIONS, INC. 

WARRANT TO PURCHASE COMMON STOCK 

Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”), for value received on August 20, 2015 (the
“Effective Date”), hereby issues to [            ] (the “Holder”) this Warrant (the “Warrant”) to purchase up to
[            ] shares of the Company’s Common Stock (as defined below) at the Exercise Price (as defined below), as adjusted from time to time as provided herein, on or before
August 20, 2023 (the “Expiration Date”), all subject to the following terms and conditions. The Warrant Shares (as defined below) issued upon exercise of this Warrant shall be subject to the provisions of the Company’s
certificate of incorporation, as in effect from time to time. Unless otherwise defined in this Warrant, terms appearing in initial capitalized form shall have the meaning ascribed to them in that certain Purchase Agreement, dated as of
August 20, 2015 by and among the Company, the Holder and certain other investors party thereto, entered into in connection with a private placement of the Company’s securities and pursuant to which this Warrant was issued (the
“Purchase Agreement”). This Warrant, together with any other Warrants issued pursuant to the Purchase Agreement or upon the transfer or exchange of all or any part of such Warrant or Warrants, are collectively referred to as the
“Warrants”, and any Holder, together with any other holder of Warrants, are collectively referred to as the “Holders”. 

As used in this Warrant: 
 (i)
“Affiliate” means any Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, a Person, as such terms are used and construed in Rule 144
promulgated under the Securities Act of 1933, as amended (the “Securities Act”); 

 (ii) “Business Day” means any day other than Saturday,
Sunday or any other day on which commercial banks in the City of New York, New York, are authorized or required by law or executive order to close; 

(iii) “Common Stock” means (i) the Common Stock, par value $0.00001 per share, of the Company, and (ii) any
share capital into which such Common Stock shall have been changed or any share capital resulting from a reclassification of such Common Stock; 

(iv) “Exercise Price” means $1.91 per whole share of Common Stock, subject to adjustment as provided herein;

 (v) “Person” means an individual, a limited liability company, a partnership, a joint venture, a
corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof; 
 (vi)
“Trading Day” means any day on which the Common Stock is traded on the primary national or regional stock exchange on which the Common Stock is listed, or if not so listed, the OTC Bulletin Board, if quoted thereon, is
open for the transaction of business, provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended
from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York City
time); and 
 (viii) “Warrant Shares” means the shares of Common Stock issuable upon exercise of the Warrant,
including any securities issued or issuable with respect thereto or into which or for which such shares may be exchanged, or converted, pursuant to any stock dividend, stock split, stock combination, recapitalization, reclassification,
reorganization or other similar event. 
  

	1.	DURATION AND EXERCISE OF WARRANT 

 (a) Exercise Period. Subject to the terms of this
Warrant, the Holder may exercise this Warrant at any time and from time to time, in whole or in part, on any Business Day on or before 5:00 P.M., Eastern Time, on the Expiration Date, at which time this Warrant shall become void and of no value, and
all rights hereunder shall thereupon cease. 
 (b) Exercise Procedures. 

  
 2 

 (i) While this Warrant remains outstanding and exercisable in accordance with Section 1(a),
the Holder may exercise this Warrant, in whole or in part, as follows: 
 (A) By presentation and surrender of this Warrant to the Company
at its principal offices or at such other office or agency as the Company may specify in writing to the Holder, with a duly executed copy of the Notice of Exercise attached as Exhibit A; and 

(B) Payment of the then-applicable Exercise Price per share multiplied by the number of Warrant Shares being purchased upon exercise of the
Warrant (such amount, the “Aggregate Exercise Price”) made in the form of cash, or by certified check, bank draft or money order payable in lawful money of the United States of America or in the form of a Cashless Exercise (as
defined below) to the extent permitted in Section 1(b)(ii) below. 
 (ii) In addition, while this Warrant remains outstanding and
exercisable in accordance with Section 1(a), the Holder may also, in its sole discretion, exercise (so long as at the time of exercise, the fair market value (as defined below) exceeds the then-current Exercise Price) all or any part of the
Warrant in a “cashless” or “net-issue” exercise (a “Cashless Exercise”) by delivering to the Company (1) the Notice of Exercise and (2) the original Warrant, pursuant to which the Holder shall surrender
the right to receive upon exercise of this Warrant, a number of Warrant Shares having a fair market value (as determined below) equal to the Aggregate Exercise Price, in which case, the number of Warrant Shares to be issued to the Holder upon such
exercise shall be calculated using the following formula: 
  

					
	 X    
	 	=	 	Y * (A - B)
		 		 	A

  

					
	with:    	 	X =    	 	the number of Warrant Shares to be issued to the Holder
			
		 	Y =	 	the number of Warrant Shares with respect to which the Warrant is being exercised
			
		 	A =	 	the fair market value per share of Common Stock on the date of exercise of the Warrant
			
		 	B =	 	the then-current Exercise Price of the Warrant

 Solely for the purposes of this Section 1(b)(ii), “fair market value” per share of Common
Stock shall mean (A) if the Common Stock is publicly traded, the average of the closing sales prices, as quoted on the primary national or regional stock exchange on which the Common Stock is listed, or, if not listed, the OTC Bulletin Board if
quoted thereon, on the twenty (20) Trading Days immediately preceding the date on which the Notice of Exercise is deemed to have been sent to the Company, or (B) if the Common Stock is not publicly traded as set forth in clause (A) of
this sentence, as reasonably and in good faith determined by the Board of Directors of the Company as of the date which the Notice of Exercise is deemed to have been sent to the Company (subject to Section 14). 

For purposes of Rule 144(d) promulgated under the Securities Act, as in effect on the date hereof, it is intended that the Warrant Shares
issued in a Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Purchase Agreement.

  
 3 

 (iii) Upon the exercise of this Warrant in compliance with the provisions of this
Section 1(b), the Company shall promptly issue and cause to be registered with the Company’s transfer agent (the “Transfer Agent”) a book entry position for the total number of Warrant Shares for which this Warrant is
being exercised. Each exercise of this Warrant shall be effective immediately prior to the close of business on the date (the “Date of Exercise”) on which the conditions set forth in Section 1(b) have been satisfied. On or
before the second Business Day following the date on which the Company has received each of the Notice of Exercise and the Aggregate Exercise Price (or notice of a Cashless Exercise in accordance with Section 1(b)(ii)) (the “Exercise
Delivery Documents”), the Company shall transmit an acknowledgment of receipt of the Exercise Delivery Documents to the Transfer Agent. Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes
to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised. If the number of Warrant Shares represented by this Warrant is greater than the actual number of Warrant Shares being acquired upon such
an exercise, then the Company shall as soon as practicable and in no event later than five (5) Business Days after any exercise, and at its own expense, issue a new Warrant of like tenor representing the right to purchase the number of Warrant
Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised. 

(c) Exercise Limitations. 

(i) Subject to the effect of a Fundamental Transaction as described in Section 3(c) below, the Company shall not effect any exercise of
this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the
Holder’s Affiliates, and any other Person acting as a group together with the Holder or any of the Holder’s Affiliates) would beneficially own any Common Stock in excess of 19.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant (the “Beneficial Ownership Limitation”). 

(ii) For purposes of the Section 1(c)(i), the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall
include, in addition to outstanding shares of Common Stock held by the Holder and its Affiliates, (x) the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made,
(y) the number of shares of Common Stock issuable upon the exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company exercisable or convertible into Common Stock beneficially owned by the Holder or
any of its Affiliates or any other person acting as a group with the Holder or any of the Holder’s Affiliates, and (z) any other shares of Common Stock then beneficially owned by the Holder or any of its Affiliates or any other person
acting as a group with the Holder or any of the Holder’s Affiliates, but shall exclude the number of shares of Common Stock which would be issuable upon exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the
Holder 

  
 4 

 
or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 1(c), beneficial ownership shall be calculated in accordance with
Section 13(d) of the Exchange Act, as amended (the “Exchange Act”) and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such
calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 1(c)
applies, the determination of which portion of this Warrant is exercisable shall be in the sole discretion of the Company, provided that the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of which portion of
this Warrant is exercisable, subject to the Beneficial Ownership Limitation, and shall be considered a representation to the Company that the Beneficial Ownership Limitation shall not be exceeded, and the Company may rely on such representation,
with no obligation to verify or confirm the accuracy of such representation, in making its own determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 1(c), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as of
the most recent date reflected in (A) the Company’s most recent periodic or annual report, as the case may be, (B) a more recent public announcement by the Company and (C) any other notice by the Company or the Transfer Agent to
the Holder setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since
the date as of which such number of outstanding shares of Common Stock was reported. The provisions of this Section 1(c) shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(c)
to correct this Section 1(c) (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. 
 (d) Partial
Exercise. This Warrant shall be exercisable, either in its entirety or, from time to time, for only part of the number of Warrant Shares referenced by this Warrant. If this Warrant is exercised in part, the Company shall issue, at its expense, a
new Warrant, in substantially the form of this Warrant, referencing such reduced number of Warrant Shares that remain subject to this Warrant. 

(e) Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in accordance with Section 15. 

  
 5 

	2.	ISSUANCE OF WARRANT SHARES 

 (a) The Company covenants that all Warrant Shares will, upon
issuance in accordance with the terms of this Warrant, be (i) duly authorized, fully paid and non-assessable, and (ii) free from all liens, charges and security interests, with the exception of claims arising through the acts or omissions
of the Holder and except as arising from applicable federal and state securities laws. 
 (b) The Company shall register this Warrant upon
records to be maintained by the Company for that purpose in the name of the record holder of such Warrant from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner thereof for the purpose of any
exercise thereof, any distribution to the Holder thereof and for all other purposes. 
 (c) The Company will not, by amendment of its
certificate of incorporation or bylaws or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of
the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all action necessary or appropriate in order to protect the
rights of the Holder to exercise this Warrant, or against impairment of such rights. 
  

	3.	ADJUSTMENTS OF EXERCISE PRICE, NUMBER AND TYPE OF WARRANT SHARES; FUNDAMENTAL TRANSACTION 

 (a)
The Exercise Price and the number of shares purchasable upon the exercise of this Warrant shall be subject to adjustment from time to time upon the occurrence of certain events described in this Section 3(a); provided, that
notwithstanding the provisions of this Section 3(a), the Company shall not be required to make any adjustment if and to the extent that such adjustment would require the Company to issue a number of shares of Common Stock in excess of its
authorized but unissued shares of Common Stock, less all shares of Common Stock that have been reserved for issuance upon the conversion of all outstanding securities convertible into shares of Common Stock and the exercise of all outstanding
options, warrants and other rights exercisable for shares of Common Stock. If the Company does not have the requisite number of authorized but unissued shares of Common Stock to make any adjustment, the Company shall use commercially reasonable
efforts to obtain the necessary shareholder consent to increase the authorized number of shares of Common Stock to make such an adjustment pursuant to this Section 3(a). 

(i) Subdivision or Combination of Stock. If the Company at any time after the date of issuance of this Warrant subdivides (by any stock
split, stock dividend, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision shall be proportionately reduced and the number of
Warrant Shares shall be proportionately increased. If the Company at any time after the date of issuance of this Warrant combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of
shares, the 

  
 6 

 
Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares shall be proportionately decreased. Any adjustment under this
Section 3(a)(i) shall become effective at the close of business on the date the subdivision or combination becomes effective. The Exercise Price and the Warrant Shares, as so adjusted, shall be readjusted in the same manner upon the happening
of any successive event or events described in this Section 3(a)(i). 
 (ii) Distribution of Assets. If at any time or from time
to time the holders of Common Stock (or any shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have received or become entitled to receive, without payment therefore: (x) Common Stock or any
shares of stock or other securities which are at any time directly or indirectly convertible into or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or
other distribution (other than a dividend or distribution covered in Section 3(a)(i) above); (y) any cash paid or payable otherwise than as a cash dividend; or (z) Common Stock or additional stock or other securities or property
(including cash) by way of spinoff, split-up, reclassification, combination of shares or similar corporate rearrangement (other than shares of Common Stock pursuant to Section 3(a)(i) above); then and in each such case, the Holder hereof will,
upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable thereupon, and without payment of any additional consideration therefor, the amount of stock and other securities and property
(including cash in the cases referred to in clauses (y) and (z) above) which such Holder would hold on the date of such exercise had such Holder been the holder of record of such Common Stock as of the date on which holders of Common Stock
received or became entitled to receive such shares or all other additional stock and other securities and property. 
 (b) Certificate as
to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 3, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the
Holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall promptly furnish or cause to be furnished to the Holder a like
certificate setting forth: (i) such adjustments and readjustments; and (ii) the number of shares and the amount, if any, of other property which at the time would be received upon the exercise of the Warrant. 

(c) Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person (but excluding a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company), (ii) the
Company, directly or indirectly, effects any sale, assignment, transfer or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or
exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of
50% or more of the outstanding Common Stock or (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of 

  
 7 

 
the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (each a “Fundamental
Transaction”), then, the Company shall cause this Warrant to be redeemed in connection with such Fundamental Transaction (which shall include an express provision in the definitive agreement related to such Fundamental Transaction to
obligate the parties to effectuate the redemption or similar repurchase or “cash out” of the Warrant as contemplated in this Section 3(c)) for the same consideration that would have been payable in respect of all of the Warrant Shares
that would have been issuable to the Holder if this Warrant had been fully exercised by Cashless Exercise on the date of, and immediately prior to, the Fundamental Transaction (without regard to any limitation in Section 1(c) on exercise of
this Warrant); for the avoidance of doubt, the Holder shall be entitled to be paid at least the same per share consideration as the other holders of the Company’s Common Stock in connection with any such Fundamental Transaction, without regard
to the Beneficial Ownership Limitation. 
  

	4.	TRANSFERS AND EXCHANGES OF WARRANT AND WARRANT SHARES 

 (a) Registration of Transfers and
Exchanges. Subject to Section 4(c), upon the Holder’s surrender of this Warrant, with a duly executed copy of the Form of Assignment attached as Exhibit B, to the Secretary of the Company at its principal offices or at such
other office or agency as the Company may specify in writing to the Holder, the Company shall register the transfer of all or any portion of this Warrant. Upon such registration of transfer, the Company shall issue a new Warrant, in substantially
the form of this Warrant, evidencing the acquisition rights transferred to the transferee and a new Warrant, in similar form, evidencing the remaining acquisition rights not transferred, to the Holder requesting the transfer. 

(b) Warrant Exchangeable for Different Denominations. The Holder may exchange this Warrant for a new Warrant or Warrants, in
substantially the form of this Warrant, evidencing in the aggregate the right to purchase the number of Warrant Shares that may then be purchased hereunder, each of such new Warrants to be dated the date of such exchange and to represent the right
to purchase such number of Warrant Shares as shall be designated by the Holder. The Holder shall surrender this Warrant with duly executed instructions regarding such re-certification of this Warrant to the Secretary of the Company at its principal
offices or at such other office or agency as the Company may specify in writing to the Holder. 
 (c) Warrant not Transferrable;
Restrictions on Transfers. This Warrant may not be transferred at any time without both (x) the consent of the Company, in its sole discretion, and (y) either (i) registration under the Securities Act or (ii) an exemption
from such registration and a written opinion of legal counsel addressed to the Company that the proposed transfer of the Warrant may be effected without registration under the Securities Act, which opinion will be in form and from counsel reasonably
satisfactory to the Company. 
 (d) Permitted Transfers and Assignments. Notwithstanding any provision to the contrary in this
Section 4, the Holder may transfer, with or without consideration, this Warrant or any of the Warrant Shares (or a portion thereof) to the Holder’s Affiliates (as such term is defined under Rule 144 of the Securities Act) without obtaining
the consent of the Company or the opinion from counsel that may be required by Section 4(c)(ii); provided that the Holder 

  
 8 

 
delivers to the Company and its counsel certification, documentation, and other assurances reasonably required by the Company’s counsel to enable the Company’s counsel to render an
opinion to the Company’s Transfer Agent that such transfer does not violate applicable securities laws. 
  

	5.	MUTILATED OR MISSING WARRANT CERTIFICATE 

 If this Warrant is mutilated, lost, stolen or
destroyed, upon request by the Holder, the Company will, at its expense, issue, in exchange for and upon cancellation of the mutilated Warrant, or in substitution for the lost, stolen or destroyed Warrant, a new Warrant, in substantially the form of
this Warrant, representing the right to acquire the equivalent number of Warrant Shares; provided that, as a prerequisite to the issuance of a substitute Warrant, the Company may require satisfactory evidence of loss, theft or destruction as
well as an indemnity from the Holder of a lost, stolen or destroyed Warrant. 
  

	6.	PAYMENT OF TAXES 

 The Company shall not be required to pay any tax in respect of the
preparation, issuance, delivery or transfer of this Warrant or the Warrant Shares to the Holder or any other Person. 
  

	7.	FRACTIONAL WARRANT SHARES 

 No fractional Warrant Shares shall be issued upon exercise of this
Warrant. The Company, in lieu of issuing any fractional Warrant Share, shall round up the number of Warrant Shares issuable to nearest whole share. The Company shall not be required to make any cash or other adjustment in respect of such fraction of
a share to which the Holder would otherwise be entitled. 
  

	8.	NO EQUITY INTEREST RIGHTS AND LEGEND 

 No holder of this Warrant, as such, shall be entitled to
vote or be deemed the holder of any other securities of the Company that may at any time be issuable on the exercise hereof, nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, the rights of a
shareholder of the Company or the right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or give or withhold consent to any corporate action or to receive notice of meetings or other actions
affecting shareholders (except as provided herein), or to receive dividends or subscription rights or otherwise (except as provide herein). 

Each certificate or book entry position for Warrant Shares initially issued upon the exercise of this Warrant, and each certificate or book
entry position for Warrant Shares issued to any subsequent transferee of such Warrant Shares, shall be stamped or otherwise imprinted with a legend in substantially the following form: 

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES 

  
 9 

 
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY NOT BE
OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS THE SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE. IN ADDITION, HEDGING TRANSACTIONS INVOLVING SUCH
SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. 
  

	9.	NOTICES 

 All notices, consents, waivers and other communications under this Warrant must be in
writing and will be deemed given to a party: (a) when delivered to the appropriate address of the Holder or the Company, as applicable, by hand or by nationally recognized overnight courier service (costs prepaid); (b) when sent by
facsimile or e-mail to the Holder or the Company, as applicable, with confirmation of transmission by the transmitting equipment; (c) when received or rejected by the addressee, if sent by certified mail, return receipt requested, to the Holder
or the Company, as applicable; or (d) seven days after the placement of the notice into the mails (first class postage prepaid), to the Holder or the Company, as applicable. Such notices shall be sent, if to the Holder, to the address,
facsimile number or e-mail address furnished by the registered Holder to the Company in accordance with the Purchase Agreement, or if to the Company, to it at 1540 Drew Ave., Davis CA 95618, Attention: Linda V. Moore, General Counsel (or to such
other address, facsimile number or e-mail address as the Holder or the Company as a party may designate by notice the other party) with a copy to Morrison & Foerster LLP, 400 Capitol Mall, Suite 2600, Sacramento, CA 95814, Attention:
Charles S. Farman, Esq. 
  

	10.	SEVERABILITY 

 If a court of competent jurisdiction holds any provision of this Warrant invalid
or unenforceable, the other provisions of this Warrant will remain in full force and effect. Any provision of this Warrant held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or
unenforceable. 
  

	11.	BINDING EFFECT 

 This Warrant shall be binding upon and inure to the sole and exclusive benefit
of the Company, its successors and assigns, the registered Holder or Holders from time to time of this Warrant and the Warrant Shares. 
  

	12.	SURVIVAL OF RIGHTS AND DUTIES 

 This Warrant shall terminate and be of no further force and
effect on the earlier of 5:00 P.M., Eastern Time, on the Expiration Date or the date on which this Warrant has been exercised in full. 

  
 10 

	13.	GOVERNING LAW 

 This Warrant shall be governed by and construed in accordance with California
law without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties. 

 

	14.	DISPUTE RESOLUTION 

 In the case of a dispute as to the determination of the Exercise Price or
the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within two (2) Business Days of receipt of the Notice of Exercise giving rise to such dispute, as
the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or arithmetic calculation
being submitted to the Holder, then the Company shall, within two (2) Business Days, submit via facsimile the disputed determination of the Exercise Price to an independent, reputable investment bank or accounting firm selected by the Company
and approved by the Holder. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten
(10) Business Days from the time it receives the disputed determinations or calculations. Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable
error. 
  

	15.	NOTICES OF RECORD DATE 

 Upon (a) any establishment by the Company of a record date of the
holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend or other distribution, or right or option to acquire securities of the Company, or any other right, or (b) any
capital reorganization, reclassification, recapitalization, merger or consolidation of the Company with or into any other corporation, any transfer of all or substantially all the assets of the Company, or any voluntary or involuntary dissolution,
liquidation or winding up of the Company, or the sale, in a single transaction, of a majority of the Company’s voting equity securities (whether newly issued, or from treasury, or previously issued and then outstanding, or any combination
thereof), the Company shall mail to the Holder at least ten (10) Business Days, or such longer period as may be required by law, prior to the record date specified therein, a notice specifying (i) the date established as the record date
for the purpose of such dividend, distribution, option or right and a description of such dividend, option or right, (ii) the date on which any such reorganization, reclassification, transfer, consolidation, merger, dissolution, liquidation or
winding up, or sale is expected to become effective and (iii) the date, if any, fixed as to when the holders of record of Common Stock shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon
such reorganization, reclassification, transfer, consolidation, merger, dissolution, liquidation or winding up. 

  
 11 

	16.	RESERVATION OF SHARES 

 The Company shall reserve and keep available out of its authorized but
unissued shares of Common Stock for issuance upon the exercise of this Warrant, free from pre-emptive rights, such number of shares of Common Stock for which this Warrant shall from time to time be exercisable. The Company will take all such
reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation. Without limiting the generality of the foregoing, the Company covenants that it will use
commercially reasonable efforts to take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents, including but not limited to consents from the Company’s shareholders or Board of Directors or any public regulatory body, as may be necessary to enable the Company
to perform its obligations under this Warrant. 
  

	17.	HEADINGS 

 The headings used in this Warrant are for the convenience of reference only and shall
not, for any purpose, be deemed a part of this Warrant. 
  

	18.	AMENDMENT AND WAIVERS 

 Any term of this Warrant may be amended and the observance of any term
of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), with the written consent of the Company and the Holders of a majority of the Warrant Shares issuable upon exercise of the
Warrants. 
  

	19.	NO THIRD PARTY RIGHTS 

 This Warrant is not intended, and will not be construed, to create any
rights in any parties other than the Company and the Holder, and no Person may assert any rights as third-party beneficiary hereunder. 

SIGNATURE PAGE FOLLOWS 

  
 12 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the date first
set forth above. 
  

			
	 MARRONE BIO INNOVATIONS, INC.

		
	                By:	 	              

		 	 Name:

		 	 Title:

 EXHIBIT A 

NOTICE OF EXERCISE 
 (To be
executed by the Holder of Warrant if such Holder desires to exercise Warrant) 
 To Marrone Bio Innovations, Inc.: 

The undersigned hereby irrevocably elects to exercise this Warrant and to purchase thereunder,
            full shares of Marrone Bio Innovations, Inc. common stock issuable upon exercise of the Warrant and delivery of: 

(1) $            (in cash as provided for in the foregoing Warrant) and any
applicable taxes payable by the undersigned pursuant to such Warrant; and 
 (2)
            shares of Common Stock (pursuant to a Cashless Exercise in accordance with Section 1(b)(ii) of the Warrant) (check here if the undersigned desires to deliver an unspecified
number of shares equal the number sufficient to effect a Cashless Exercise). 
 The undersigned requests that such shares be issued in the
name of: 
  

	
	  

	(Please print name, address and social security or federal employer
identification number (if applicable))
	
	  

	
	  

 If the shares issuable upon this exercise of the Warrant are not all of the Warrant Shares which the Holder is
entitled to acquire upon the exercise of the Warrant, the undersigned requests that a new Warrant evidencing the rights not so exercised be issued in the name of and delivered to: 

 

	
	  

	 (Please print name, address and social security or federal employer

identification number (if applicable))

	
	  

	
	  

  

			
	 Name of Holder (print): 
	 	 

 
			
		
	 (Signature): 
	 	 

 
			
	 (By:) 
	 	 

 
			
		
	 Title: 
	 	 

 
			
	 Dated: 
	 	 

  

 EXHIBIT B 

FORM OF ASSIGNMENT 
 FOR VALUE
RECEIVED,                     hereby sells, assigns and transfers to each assignee set forth below all of the rights of the undersigned under the
Warrant (as defined in and evidenced by the attached Warrant) to acquire the number of Warrant Shares set opposite the name of such assignee below and in and to the foregoing Warrant with respect to said acquisition rights and the shares issuable
upon exercise of the Warrant: 
  

					
	 Name of Assignee
	  	Address	  	Number of Warrant Shares
		  		  	
		  		  	
		  		  	
		  		  	

 If the total of the Warrant Shares are not all of the Warrant Shares evidenced by the foregoing Warrant, the
undersigned requests that a new Warrant evidencing the right to acquire the Warrant Shares not so assigned be issued in the name of and delivered to the undersigned. 

			
	 Name of Holder (print): 
	 	 

 
			
		
	 (Signature): 
	 	 

 
			
	 (By:) 
	 	 

 
			
		
	 Title: 
	 	 

 
			
	 Dated:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}]]